DSM is an outsourcing manufacturing partner committed to meeting market demand globally with quality, regulatory excellence and innovations for sustainability.

DSM offers preclinical/R&D through Phase I, II and III to commercial scale production for active pharmaceutical ingredients, biologics (mammalian cell cultures), microbial fermentation, anti-infectives and, sterile and solid dosage manufacturing.

• DSM providers finished dosage form manufacturing and related services with capabilities in aseptic filling of liquid and freeze-dried compounds, tablets, capsules, and clinical trial material manufacturing for solid and injectable forms.
• In pharma chemicals, DSM offers customer oriented chemical process development and production of APIs (active pharmaceutical ingredient) but also on registered intermediates which are used in the production of various innovative drugs.
• In Biologics, DSM is a provider of manufacturing technology and services to the biopharmaceutical industry, and develops technologies relevant for optimized mammalian cell culture processes.
• Additionally, in dedicated facilities, DSM offers microbial fermentation and technology to identify optimal microbial hosts for the production of proteins.

DSM – Bright Science. Brighter Living.™
Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM’s 22,000 employees deliver annual net sales of about € 9 billion.

Royal DSM N.V. (DSM KON, NYSE Euronext)
#1 on the Dow Jones Sustainability Index 2010